ZymeTx's IPO

ZymeTx raised a round of funding on October 29, 1997. Investors include Public.

ZymeTx is a biotechnology company that engages in the development of products for the diagnosis and treatment of viral disease, viral management, and disease surveillance. ViraZyme, its core technolog…

Articles about ZymeTx's IPO: